Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma.

Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma.
复制标题

DOI:
10.1038/s41408-022-00635-3
复制
发表时间:
2022-04-01
影响因子:
12.8
通讯作者:
Anderson KC
Anderson KC
中科院分区:
医学1区
文献类型:
--
作者:
Ray A;Song Y;Du T;Buon L;Tai YT;Chauhan D;Anderson KC

文献摘要

参考文献

被引文献

相似文献

浆细胞样树突状细胞(pDC)与多发性骨髓瘤(MM)细胞、T或NK效应细胞在骨髓(BM)微环境中的相互作用诱导肿瘤细胞生长,以及抑制先天性和适应性免疫应答。定义pDC-MM相互作用触发的免疫抑制机制将使介入治疗的设计能够增强抗MM免疫力。在本研究中,我们表明pDC-MM相互作用诱导pDC和MM细胞中的代谢酶Ecto-5'核苷酸酶/CD 73。MM患者的基因表达数据库显示,CD 73水平与总生存率呈负相关。使用我们的pDC-MM共培养模型,我们发现用抗CD 73 Ab阻断CD 73:降低腺苷水平;激活MM患者pDC;触发针对自体患者MM细胞的细胞毒性T淋巴细胞(CTL)活性。抗CD 73抗体和免疫刺激剂TLR-7激动剂的组合增强自体MM特异性CD 8 + CTL活性。总之,我们的临床前数据表明,单独或与TLR-7激动剂组合的CD 73治疗靶向代表了恢复宿主抗MM免疫力的有前景的新策略。
Interaction of plasmacytoid dendritic cells (pDCs) with multiple myeloma (MM) cells, T- or NK-effector cells in the bone marrow (BM) microenvironment induces tumor cell growth, as well as inhibits innate and adaptive immune responses. Defining pDC-MM interaction-triggered immunosuppressive mechanism(s) will enable design of interventional therapies to augment anti-MM immunity. In the present study, we show that pDC-MM interactions induce metabolic enzyme Ecto-5' Nucleotidase/CD73 in both pDCs and MM cells. Gene expression database from MM patients showed that CD73 levels inversely correlate with overall survival. Using our pDC-MM coculture models, we found that blockade of CD73 with anti-CD73 Abs: decreases adenosine levels; activates MM patient pDCs; triggers cytotoxic T lymphocytes (CTL) activity against autologous patient MM cells. Combination of anti-CD73 Abs and an immune-stimulating agent TLR-7 agonist enhances autologous MM-specific CD8+ CTL activity. Taken together, our preclinical data suggest that the therapeutic targeting of CD73, alone or in combination with TLR-7 agonist, represents a promising novel strategy to restore host anti-MM immunity.
DOI: 10.1016/j.jhep.2017.12.007
发表时间: 2018-05-01
影响因子: 25.7
作者:
Niu, Congrong;Li, Li;Fletcher, Simon P.
通讯作者: Fletcher, Simon P.
细胞外嘌呤,嘌呤能受体和肿瘤生长。
DOI: 10.1038/onc.2016.206
发表时间: 2017-01-19
期刊: Oncogene
影响因子: 8
作者:
Di Virgilio F;Adinolfi E
通讯作者: Adinolfi E
DOI: 10.1016/j.ccr.2009.08.019
发表时间: 2009-10-06
期刊: Cancer cell
影响因子: 50.3
作者:
Chauhan D;Singh AV;Brahmandam M;Carrasco R;Bandi M;Hideshima T;Bianchi G;Podar K;Tai YT;Mitsiades C;Raje N;Jaye DL;Kumar SK;Richardson P;Munshi N;Anderson KC
通讯作者: Anderson KC
DOI: 10.1038/nrdp.2017.46
发表时间: 2017-07-20
影响因子: 81.5
作者:
Kumar, Shaji K.;Rajkumar, Vincent;Anderson, Kenneth C.
通讯作者: Anderson, Kenneth C.
DOI: 10.1038/s41375-018-0062-8
发表时间: 2018-09
期刊: Leukemia
影响因子: 11.4
作者:
Bae J;Hideshima T;Tai YT;Song Y;Richardson P;Raje N;Munshi NC;Anderson KC
通讯作者: Anderson KC